Join the AGITG and help improve outcomes for people with Gastro-Intestinal (GI) cancer

For more than 30 years, the Australasian Gastro-Intestinal Trials Group (AGITG) has been conducting research to improve treatments and quality of life for people with GI cancer. Our research has been integral to worldwide changes in practice and provided patients with new cutting edge treatments and high care support not otherwise available.

Our core value is in bringing a range of different clinicians, researchers and community members together to generate ideas and progress research to address unmet needs in GI cancers.

Our Members

The AGITG membership of more than 1,500 encompasses a wide range of medical specialists, scientists, nurses, allied health professionals and community members with a lived experience of GI cancer from Australia, New Zealand and around the world. Together, our members not only bring diverse experience and skills, but the collective technical and logistical capability necessary to perform innovative clinical trials and translational research.

Our leaders promote a culture of innovation, passion and goodwill. They also ensure we have robust, accountable and transparent processes for research development and funding decisions.

Why join the AGITG?

Member opportunities include:

  • Access to a range of research development pathways;
  • Access to exclusive grant funding from philanthropic and community sources;
  • Participation on research committees;
  • Participation in AGITG trials and involvement in Trial Management Committees;
  • Networking opportunities at the Annual Scientific Meeting and other events throughout the year;
  • Voting rights at the Annual General Meeting; and
  • Regular communications including research updates.

We are always working to advance opportunities for member involvement. Shared positions and consultant roles for our Upper and Lower GI Working Parties were introduced recently. These roles provide flexibility between two members to share one position, enabling greater input from all disciplines and providing more opportunities for members to be involved in our research development.

The introduction of early career researcher Co-Chair positions for our clinical trials is another great example of providing new ways for researchers to be involved and encouraging the next generation of leaders.

Providing new research development pathways is essential to the success of the AGITG. There are many ways our members can present and develop their research including submitting a concept to the Upper and Lower GI Working Parties, presenting at the New Concepts Symposium and taking part in an Idea Generation Workshop.

We have a distinguished history of conducting phase II and III trials with academic coordinating centres. However, with the development of a new research strategy, new opportunities will arise as we establish in-house and phase I coordination models to conduct investigator-led research, expand capacity for trial coordination, and deliver a biological sample repository to support innovative pre-clinical research.

There has never been a better time to join the AGITG and play an active role in improving outcomes for the 33,200 Australians and 5,700 New Zealanders diagnosed with GI cancer every year.

Want to learn more before joining?

Click here to complete the AGITG Confidentiality and Conflict of Interest Declaration.

Share